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Abstract
Lipid membranes are suggested as the primary target of amyloid aggregates. We study aggregates 
formed by a polyglutamine (polyQ) peptide, and their disruptive effect on lipid membranes. Using 
solution atomic force microscopy (AFM), we observe polyQ oligomers coexisting with short 
fibrils, which have a twisted morphology that likely corresponds to two intertwined oligomer 
strings. Fourier transform infrared spectroscopy reveals that the content of β-sheet enriched 
aggregates increases with incubation time. Using fluorescence microscopy, we find that exposure 
to polyQ aggregates results in deflated morphology of giant unilamellar vesicles. PolyQ 
aggregates induced membrane disruption is further substantiated by time-dependent calcein 
leakage from the interior to the exterior of lipid vesicles. Detailed structural and mechanical 
perturbations of lipid membranes are revealed by solution AFM. We find that membrane 
disruption by polyQ aggregates proceeds by a two-step process, involving partial and full 
disruption. In addition to height contrast, the resulting partially and fully disrupted bilayers have 
distinct rigidity and adhesion force properties compared to the intact bilayer. Specifically, the 
bilayer rigidity increases as the intact bilayer becomes partially and fully disrupted. Surprisingly, 
the adhesion force first decreases and then increases during the disruption process. By resolving 
individual fibrils deposited on bilayer surface, we show that both the length and the number of 
fibrils can increase with incubation time. Our results highlight that membrane disruption could be 
the molecular basis of polyQ aggregates induced cytotoxicity.
Abstract
*To whom correspondence should be addressed: Jianjun Pan, Ph.D., panj@usf.edu. 
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
HHS Public Access
Author manuscript
Biochim Biophys Acta. Author manuscript; available in PMC 2017 April 01.
Published in final edited form as:
Biochim Biophys Acta. 2016 April ; 1858(4): 661–670. doi:10.1016/j.bbamem.2016.01.016.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Keywords
polyglutamine; amyloid; oligomer; lipid bilayer; solution AFM; fluorescence microscopy
Introduction
To date, it is known that misfolding of expanded polyglutamine (polyQ) stretches is 
responsible for at least ten types of neurodegenerative disorders in human [1]. Among them, 
Huntington’s disease (HD) is the most notable one. HD is caused by an abnormal polyQ 
stretch located near the N-terminus of the protein huntingtin (htt). It was found that the risk 
of developing HD, as well as the severity of the disease, is greatly enhanced when the 
number of glutamine repeats reaches a pathogenic threshold [2]. Numerous biochemical and 
biophysical studies have indicated that polyQ stretches have the generic amyloidogenetic 
propensity of forming protease resistant aggregates, a common theme shared by many 
amyloid proteins and peptides, including amyloid-β in Alzheimer’s disease, α-synuclein in 
Parkinson’s disease, islet amyloid polypeptide in type II diabetes mellitus, and prion protein 
in Creutzfeldt-Jakob disease.
One hallmark of HD is the formation of fibrillar inclusion bodies in intranuclear and 
cytoplasmic spaces. Kinetic studies using model peptides have established that polyQ fibrils 
are formed following classic nucleated polymerization mechanism [3, 4]. Additional studies 
suggested that the nucleus size is dependent on polyQ repeat length [5]; flanking sequences 
associated with htt can further alter polyQ aggregation behavior and kinetics [6, 7]. The 
existence of polymorphic aggregates complicates structure-dysfunction relationship in 
polyQ associated disorders, i.e., what is the molecular species responsible for cytotoxicity 
along the pathogenic pathway [8]? Indeed, both mature fibrils [9-11] and elusive oligomers 
[12-18] have been documented as the toxic determinant.
Studies comparing molecular bases of amyloidogenic diseases indicated that despite 
sequence diversity, all amyloid oligomers share a common conformation that is ubiquitously 
recognized by specifically designed antibodies [13]. Electrophysiological measurements 
revealed that all soluble oligomers increased membrane ion conductivity, while fibrils had 
no such effect. Based on these observations, a common mechanism of membrane targeting 
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and permeabilization was conceptualized [19]. This view was reinforced by observations 
that amyloid pathogenesis can be caused by aggregates localized either in the extracellular 
or cytosolic space. In addition, cytotoxicity was conserved when cytosolic aggregates were 
administered externally [13, 19]. In line with the membrane permeabilization mechanism, 
many amyloidogogenic proteins and peptides were found to reorganize membrane structure, 
such as α-synuclein [20], amyloid-β [21], islet amyloid polypeptide [22], and prion protein 
fragment [23]. Membrane disruption by polyQ aggregates has also been observed. In 
particular, both polyQ repeat length [24] and flanking sequence [25] were found to play a 
role in modulating membrane integrity.
Despite the accumulating knowledge, molecular basis of polyQ induced membrane 
disruption remain poorly understood. For example, it is unclear what molecular species of 
polyQ causes membrane depolarization. Large amorphous polyQ aggregates that do not 
correspond well to either oligomeric or fibrillar structures were observed on bilayer surfaces 
[24]. Are these amorphous aggregates causing lipid bilayer disruption, or are they just 
loosely associated with bilayer surface due to electrostatic interactions? Similarly, large 
aggregates of polyQ with better-defined morphologies have been observed on bilayer 
surfaces [25]. The authors referred to these aggregates as “oligomers”. One intriguing fact is 
that these “oligomers” are much larger compared to soluble oligomers observed on mica 
surface. How are these “oligomers” generated? Are they responsible for lipid bilayer 
permeabilization? AFM based studies have shown that polyQ aggregates enhance lipid 
membrane roughness, a structural feature that might be related to lipid membrane 
depolarization [24, 25]. However, it is unclear what species is causing membrane 
roughening. Finally, the details of polyQ aggregates induced membrane disruption are 
unknown. Are membranes permeabilized by amyloid pores [26] or by nonspecific 
membrane disruption [19]? The molecular mechanism of membrane disruption is further 
confounded by observations that membrane surface can alter amyloid aggregation [27, 28]. 
By suppressing aggregates’ mobility, lipid membranes can either catalyze amyloid 
aggregation [29] or reverse the aggregated product [30].
Here we use a simple lipid bilayer system to study the interplay between polyQ aggregates 
and the underlying lipid matrix. We first use solution AFM to obtain structures of polyQ 
aggregates generated by our modified preparation protocol. Our solution AFM measurement 
shows that globular oligomers and short fibrils coexist on mica surface. The secondary 
structure of polyQ as a function of incubation time is revealed by attenuated total reflection 
Fourier transformation infrared (FTIR) spectroscopy. To qualitatively assess membrane 
perturbation imparted by polyQ aggregates, we use fluorescence microscopy of ~30 μm 
sized giant unilamellar vesicles (GUVs) and fluorescence spectroscopy of ~120 nm sized 
unilamellar vesicles (ULVs). Membrane perturbation is confirmed by morphological 
changes of GUVs and time-dependent calcein leakage from ULVs. Finally, we use solution 
AFM to investigate polyQ induced structural and mechanical perturbation of mica supported 
planar lipid bilayers. We find that membrane disruption is a two-step process involving 
partial and full disruption. The resulting partially and fully disrupted bilayers have district 
structural, mechanical, and adhesion force properties. Our solution AFM also shows 
individual fibrils deposited on bilayer surfaces. Interestingly, we find that bilayer associated 
fibrils can grow in length. Based on our high-resolution data, we speculate that polyQ 
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oligomers are the toxic species causing lipid bilayer disruption. Our experimental data 
highlight that membrane disruption by polyQ aggregates can be the molecular basis of 
polyQ induced cytotoxicity.
Materials and Methods
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and rhodamine-DPPE (1,2-dipalmitoyl-
sn-glycero-3-phosphoethanolamine), in powder form, were purchased from Avanti Polar 
Lipids (Alabaster, AL). All other reagents were purchased from Fisher Scientific 
(Pittsburgh, PA).
PolyQ35 peptide (KK-Q35-KK) was synthesized by solid phase synthesis method. To 
enhance water solubility, the polyQ stretch was flanked by two lysine residues at the N- and 
C-termini. The flanking residues likely modify aggregation kinetics [31], although the 
resulting aggregates seem to be unchanged [32]. Synthesized peptide was purified by HPLC, 
followed by lyophilization. Peptide molecular weight was confirmed by a mass spectrometer 
(Bruker AutoFlex MALDI-TOF). PolyQ35 aggregates were prepared by dissolving peptide 
powder (100 μM) in 10 mM HEPES at pH 7.4. The stock solution was kept at 4.0°C. 
Aliquots incubated for different days were used for FTIR, fluorescence microscopy, and 
solution AFM measurements. (All measurements were performed at room temperature). For 
calcein leakage experiment, peptide aliquots were collected at different time points, snap-
frozen in liquid nitrogen, and stored at −80°C. Ice-thawed aliquots were mixed with calcein-
encapsulated ULVs for calcein leakage assay.
Attenuated total refection FTIR
Attenuated total reflection FTIR measurements at room temperature (23°C) were performed 
using a Vertex 70 Bio ATRII spectrometer (Bruker, Billerica, MA). A fresh aliquot (30 μl) 
of polyQ35 incubated for different days at 4°C was loaded into the silicon crystal sample 
cell. For pelleted aggregates, an aliquot incubated for 7 days was centrifuged at 13000 rpm 
for 10 min. The pellet was washed for 3 times before bringing to the initial volume. Infrared 
absorption spectra were collected at wavenumbers from 400 to 4000 cm−1 with a resolution 
of 2 cm−1 (averaged over 1500 scans). The time takes for one dataset collection is ~40 min. 
Spectra were corrected for background absorption arising from the 10 mM HEPES buffer.
Fluorescence microscopy
DOPC+0.2mol% rhodamine-DPPE were prepared by mixing appropriate amount of lipid 
stock solutions. After depositing onto ITO coated glass slides, lipid dry films were 
vacuumed for > 2 h to remove organic solvents. A GUV production chamber filled with 100 
mM sucrose and 10 mM HEPES (pH 7.4) was formed by sealing lipid dry films with a 
Viton O-ring. The assemblage was heated to 60°C using a Digi-Sense temperature 
controller. GUVs were generated by lipid swelling under an AC field of 10 Hz and 2.0 Volt 
(duration of 2 h). GUV solution was transferred to 3 mL buffer containing 100 mM glucose 
and 10 mM HEPES (pH 7.4). After settling for > 1 h, GUV aliquot from the bottom was 
transferred onto a coverslip and examined by fluorescence microscopy using a Nikon 
Eclipse-U microscope and an Andor iXon Ultra 897 EM-CCD. To retard liquid evaporation, 
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the cover slip was housed in a homemade hollow chamber sealed by copper plates and 
thermal insulation foam. To study the effect of polyQ35 aggregates, an equal volume of 
peptide solution (after adjusting glucose concentration to 100 mM) was mixed with a GUV 
aliquot (final peptide concentration was 15 μM). Immediately after mixing, time-lapse or 
single-shot fluorescence micrographs were collected. Control experiments were performed 
by mixing buffer-only solution with the GUV aliquot.
Calcein leakage assay
DOPC dry film was hydrated by 1 mL 10 mM HEPES buffer (pH 7.4) containing 20 mM 
NaCl and 30 mM calcein. Freeze-thaw cycles (6 times total) between −80 and 50°C were 
carried out to ensure uniform distribution of calcein. The resultant lipid suspension was 
extruded using an Avanti mini-extruder outfitted with a 100-nm-diameter pore filter to 
produce ULVs. An ÄKTA pure FPLC (GE Healthcare, Piscataway, NJ) and a gel filtration 
column (Superdex 200 10/300 GL) were used to remove exterior calcein. The elution buffer 
contained 108 mM NaCl and 10 mM HEPES pH 7.4 (elution buffer). The equality of the 
osmotic pressure in the interior and at the exterior of calcein-encapsulated ULVs was 
confirmed using a Wescore 5500 vapor pressure osmometer (Logan, Utah). Dynamic light 
scattering measurement using a Dynapro Nanostar (Wyatt Technology, Santa Barbra, CA) 
indicated that the size exclusion chromatography (SEC) separated vesicles had an average 
diameter of 120 nm.
Snap-frozen polyQ35 aliquots collected at different time points were thawed on ice. In 
addition to these aliquots, we also investigated the effect of pelleted aggregates. This was 
done by centrifuging 100 μL peptide solution incubated for 7 days at 13000 rpm for 10 min. 
Peptide pellet was washed by SEC elution buffer for 3 times before bringing the final 
volume to 100 μL. ULV sample was prepared by mixing 100 μL peptide solution (100 μM) 
with 880 μl SEC elution buffer; 20 μl calcein-encapsulated ULVs was added at last (final 
peptide concentration was 10 μM). The mixture was immediately transferred into a 1 mL 
quartz cuvette. Time-course fluorescence spectrum (23°C) was obtained using a Jasco 
FP-8300 fluorometer (Easton, MD). The excitation and emission wavelengths were 494 and 
515 nm, respectively, with a bandwidth of 2.5 nm for each wavelength. Fluorescence signal 
I was collected every 20 s until the intensity reached a plateau. To obtain the maximum 
intensity Imax when all calcein molecules become unenclosed, an aliquot of Triton X-100 
was added to the peptide treated ULV sample. The percentage of calcein leakage is defined 
as: F = (I - I0)/(Imax - I0) × 100%, where I0 is the fluorescence intensity from calcein-
encapsulated ULVs without peptide treatment.
Solution AFM
A liquid-compatible Multimode 8 AFM (Bruker, Santa Barbara, CA) operated at the 
PeakForce quantitative nanomechanics (QNM) mode was used for solution AFM study 
(23°C). Fresh peptide aliquot (incubated for different days at 4°C) was diluted to 10 μM (10 
mM HEPES at pH 7.4) and loaded into the AFM liquid cell, which contained a freshly 
cleaved mica substrate. After equilibration (~10 min), peptide aggregates were scanned (in 
solution) using a special silicon nitride tip that works with the PeakForce QNM mode 
(model: Scanasyst-Fluid+). Square images were acquired at a scan rate of 0.6 Hz.
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We also study the effect of polyQ35 aggregates on mica supported lipid bilayers. 
Experimental procedure for lipid bilayer preparation has been described before [33, 34]. 
Briefly, lipid small unilamellar vesicles (SUVs) in 10 mM HEPES pH 7.4 were generated by 
ultrasonication using a Sonic Dismembrator. A mica supported lipid bilayer was formed by 
injecting SUVs into the AFM liquid cell. After bilayer formation (~30 min, examined by 
preliminary AFM scans), polyQ35 aggregates (20 μM) were injected into the liquid cell 
using a syringe pump (50 μL/min). In situ AFM scans using PeakForce QNM mode were 
performed with a peak force of ~300 pN. During each scan, the probe oscillates at 1 kHz 
while it scans across the bilayer surface. On fly analysis of the oscillating force curves at 
each position yields a map of mechanical property (i.e., the reduced Young’s modulus E*) 
and another map of the adhesion force Fadh between the bilayer and the AFM tip (Fig. S1, 
SI). Both maps have the same spatial resolution as the height image. All maps (e.g., height, 
reduced Young’s modulus, and adhesion force) with the same resolution were collected in a 
single scan.
Results
Oligomer and fibril morphologies of polyQ35 revealed by solution AFM
Amyloidogenic peptides can undergo different aggregation pathways, yielding polymorphic 
oligomers, prefibrils, and fibrils [35]. Monomeric disaggregation using organic solvents is 
typically used to study aggregation kinetics of polyQ peptides [36]. Here we are only 
interested in different forms of polyQ35 aggregates interacting with lipid bilayers; therefore, 
we prepare polyQ35 aggregates by directly dissolving lyophilized powder in HEPES buffer 
(pH 7.4) without the intervening disaggregation process. To slow down polyQ aggregation, 
we keep peptide stock solution at 4°C when not in use. By taking aliquots incubated for 
different days at 4°C, we are able to obtain different proportions of polyQ35 aggregates (i.e., 
oligomers and fibrils).
High-resolution structures of polyQ35 aggregates are obtained by solution AFM (Fig. 1). 
Height profiles indicate that oligomers have a height of ~2 nm and an apparent width of ~10 
nm. We use a spherical model to correct oligomer width influenced by the finite size of the 
AFM tip (nominal radius of 2 nm): Woligomer=W2/8rtip, where W is the apparent width. The 
corrected oligomer width is 6.2 nm, which gives rise to an oligomer volume, 
2π(Woligomer/2)2h/3, of 40 nm3. To estimate the number of monomers per oligomer, we 
need to know monomer volume. Assuming a density range of 1.2 to 1.5 g/ml for polyQ35 
[37], the resulting monomer volume is 3.8 to 3.0 nm3. This gives rise to an estimation of ~10 
to 13 monomers per oligomer. We note that in addition to peptide density, AFM tip size also 
contributes greatly to the uncertainty of the estimated number of monomers per oligomer.
Fibrils are observed to coexist with oligomers (Fig. 1). Height profiles in two directions 
indicate that fibrils have a height of ~4 nm, about twice of the oligomer height. Moreover, 
twisted morphology is revealed by periodic height distribution along the fibril axis 
(periodicity of ~13 nm). These observations suggest that polyQ35 fibrils might be formed by 
intertwining two oligomer strings.
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At 4°C, polyQ35 undergoes slow aggregation, yielding different proportions of monomers, 
oligomers, and fibrils. Figure 2 shows four aliquots incubated for different days at 4°C. We 
note that polyQ are known to aggregate at room temperature when equilibrating in the AFM 
liquid cell; more aggregates (oligomers and fibrils) are observed with longer incubation at 
room temperature. The images in Fig. 2 are obtained with similar incubation time after 
injection into the liquid cell. It is clear that the amount of aggregates increases with the 
incubation days at 4°C. Amorphous aggregates are observed when there are abundant fibrils 
(Fig. 2C and 2D). Globular oligomers with similar sizes are observed in all images. Height 
probabilities indicate that the fibril height is independent on incubation time (Fig. 2E–2H). 
Note that fibril peaks are located at ~3 nm, a value smaller than the fibril height estimated 
from Fig. 1. This is due to the cylindrical shape of fibrils (only fibril apex has the maximum 
height of ~4 nm).
Secondary structure of polyQ35 aggregates revealed by FTIR
To evaluate the secondary structure of polyQ35 aggregates after incubating for different 
days, we use attenuated total reflection FTIR in solution. Similar to the AFM experiment, it 
is expected (and experimentally confirmed) that polyQ35 undergoes aggregation when 
equilibrating in the FTIR liquid cell. For this reason, we only compare the first scan after 
transferring a fresh aliquot from the stock solution at 4°C. The absorption spectra for 
aliquots incubated from 0 to 7 days are shown in Fig. 3. We also pelleted aggregates for an 
aliquot incubated for 7 days (see Materials and Methods). The absorption spectrum for the 
pellet is also displayed. Two major bands located at 1655 and 1607 cm−1 corresponding to 
loop/turn and intermolecular β-sheet structures, respectively, are highlighted by dashed lines 
[38, 39]. It is clear that the loop/turn band is progressively weakened while the β-sheet band 
is enhanced (the largest change takes place during the first day of incubation). The observed 
transition is consistent with our AFM data, which show that the amount of β-sheet enriched 
aggregates increases with incubation days. Interestingly, the pelleted aggregates also display 
a small loop/turn band. This can be explained by considering that polyQ aggregates contain 
a small fraction of loop/turn motif.
GUV disruption revealed by fluorescence microscopy
We use fluorescence microscopy of DOPC GUVs (diameter of ~30 μm) to qualitatively 
study membrane perturbation endowed by polyQ35 aggregates. For the intact GUV, 
fluorescent lipid rhodamine-DPPE is uniformly distributed over the vesicle (Fig. 4). 
Addition of an equal volume of polyQ35 solution (incubated for 5 days at 4°C) results in 
lipid bilayer disruption. This is clearly illustrated by the five vesicles with deflated shapes. 
We note that addition of the same volume of HEPES buffer does not induce any vesicle 
deformation. Moreover, the observed perturbation does not take place immediately 
following the introduction of polyQ35; the majority of vesicle breakage occurs in ~10 min 
after mixing.
Vesicle disruption revealed by calcein leakage
Our GUV experiment clearly shows that polyQ35 can induce lipid bilayer disruption. To 
assess the kinetic impact of polyQ35 on membrane integrity, we use fluorescence 
spectroscopy. Calcein-encapsulated ULVs (diameter of ~120 nm) are prepared by the 
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extrusion method, followed by SEC separation. Fluorescence intensity from intact vesicles is 
small due to calcein self-quenching. When vesicles become leaky to calcein, the 
fluorescence intensity increases; the increased amount is correlated with calcein leakage or 
the degree of membrane disruption. We monitor calcein fluorescence for vesicles mixed 
with polyQ35 incubated for 0, 1, and 6 days at 4°C, as well the pelleted aggregates from a 7-
day aliquot. The final peptide concentration in mixture is 10 μM. The same SEC portion of 
calcein-encapsulated ULVs is used to eliminate lipid concentration variation. For the 0-day 
aliquot, the degree of calcein leakage increases rapidly during the first few hours of mixing 
(Fig. 5). The degree of calcein leakage levels off near ~8 h. Interestingly, only a fraction of 
calcein molecules are released from vesicle interior even when the maximum leakage is 
reached (i.e., maximum leakage < 100%). This indicates that even at maximum leakage, the 
impaired lipid membrane is not completely damaged, i.e., a membrane barrier still exists to 
prevent enclosed calcein from diffusing away. For aliquots incubated with 1 day and 6 days, 
the maximum calcein leakage becomes less compared to the 0-day aliquot. Interestingly, 
calcein leakage is also observed for the pelleted aggregates, albeit with longer equilibration 
time required to reach leakage saturation.
Disruption of mica supported lipid bilayers revealed by solution AFM
Both GUV and calcein leakage data indicate that polyQ35 confer a time-dependent 
disruptive effect on lipid bilayers. To obtain detailed structural and mechanical impact of 
polyQ35 on lipid bilayers, we use solution AFM. Mica supported planar DOPC bilayers are 
prepared in the AFM liquid cell. To test whether polyQ35 monomers play a role in 
modulating lipid bilayer structure, we first expose the DOPC bilayer to monomeric 
supernatant, which was obtained by ultracentrifuging 20 μM polyQ35 powder dissolved in 
10 mM HEPES pH 7.4 (maximum RCF of 266,000×g for 5 h). After incubating for 2 h in 
the liquid cell, very little change of the DOPC bilayer was observed (data not shown). This 
leads us to conclude that polyQ35 monomers do not disrupt bilayers, a result consistent with 
previous findings [13, 19]. We next expose DOPC bilayers to aliquots of 20 μM polyQ35 
incubated for different days at 4°C. Time-dependent bilayer remodeling is observed. This is 
illustrated in Fig. 6 for the 0-day aliquot. Since monomers are not responsible for bilayer 
disruption, the observed bilayer restructuring must be due to aggregated forms of polyQ35 
(i.e., oligomers and fibrils).
In addition to height images, high-resolution maps of the reduced Young’s modulus E* and 
the adhesion force Fadh are also shown in Fig. 6 (see Supplementary Material for the 
derivation of E* and Fadh from PeakForce QNM mode scanning). Using the thin shell theory 
for lipid bilayers, the reduced Young’s modulus is proportionally associated with bilayer 
lateral compressibility modulus KA and bilayer bending modulus KC: KA = H × E* / (1 - v2) 
and KC = H3 × E* /24 (1 - v2, where H is the bilayer thickness and v is the Poisson ratio. It is 
clear that both KA and KC are proportional to E*; a larger E* reflects a larger rigidity of the 
bilayer. The adhesion force Fadh from AFM retracting force-distance curves characterizes 
the strength of interactions between the bilayer surface and the AFM tip. Typically, 
molecules such as lipids that have a tendency of being pulled out by the AFM tip exhibit 
larger Fadh than those that are rigid such as amyloid fibrils.
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The time-dependent height images in Fig. 6 show that after exposing to polyQ35 aggregates, 
the DOPC bilayer is gradually modified. Regions corresponding to the intact bilayer (e.g., 
region a) are first converted into partially disrupted organization (e.g., region b), which is 
then further disrupted to form the fully disrupted bilayer (e.g., region c). During the 
disruption process, fibrils are observed to deposit on bilayer surfaces, mainly in partially and 
fully disrupted regions. This indicates that the interactions between fibrils and lipid bilayers 
may not be strong enough for fibril deposition. Exposure of buried lipid motifs facilitates the 
sorting of fibrils onto the bilayer surface. Height probabilities of the three height images 
(Fig. 6J) reveal that the disrupted bilayer has a smaller height than the intact bilayer. This is 
further illustrated by height profiles crossing the bilayer surface (Fig. 7). For intact bilayer, 
the height variation is small (rmsd ≈ 0.06 nm). Similar height variation is observed for the 
unperturbed region a; partial (region b) and full (region c) disruption results in ~0.2 and ~0.6 
nm height decrease, respectively. Notice that both the partially and fully disrupted regions 
exhibit larger roughness compared to the intact bilayer.
Examination of Fig. 6C indicates that there are numerous small patches on the bilayer 
surface. AFM scans with larger magnification reveal that these small patches can have 
circular or irregular shapes depending on the degree of bilayer disruption and the incubation 
days of polyQ35 at 4°C (Fig. 8). After extracting the three species present in Fig. 8 (i.e., 
fibrils, circularly or irregularly shaped patches, and the fully disrupted region) using 
appropriate height thresholds, we find that the patches have an average height larger than 
that of the fully disrupted region by ~0.6 nm (Fig. 8G and 8H). Compared to the height 
profiles in Fig. 7, the height difference of ~0.6 nm suggests that these patches correspond to 
intact bilayer regions, rather than polyQ35 oligomers. This statement is further supported by 
our analysis of bilayer material and adhesion force properties as discussed below.
In addition to height contrasts between the intact, the partially and the fully disrupted 
bilayers in Fig. 6, the simultaneously obtained reduced Young’s modulus maps indicate that 
the fully disrupted region has the largest rigidity, followed by the partially disrupted and the 
intact regions (Fig. 6D). We note that (i) the obtained rigidity is a collective mechanical 
property incorporating lipids and peptide aggregates in each pixel, and (ii) the absolute 
values of E* are dependent on scanning parameters and the AFM tip. Nevertheless, the 
relative rigidities between different regions on the bilayer surface are accurately reflected by 
the reduced Young’s modulus map. The observed rigidity contrasts between the three 
regions in Fig. 6D can be understood by considering that regions with larger amount of 
polyQ35 aggregates, which causes bilayer disruption, have larger rigidity than that of fluid 
phase lipids. Similar to the rigidity map, the adhesion force map shows that there are distinct 
contrasts between the three types of bilayer regions (Fig. 6G). While it is expected that the 
intact region has the largest adhesion force, the smaller adhesion force for the partially 
disrupted region than that of the fully disrupted region is quite surprising (Fig. 6G). This 
observation can be reconciled by considering that the fully disrupted region exposes 
adhesive lipid motifs such as the interfacial hydrocarbon chains, which are still buried in the 
partially disrupted region. Consequently, the adhesion force experienced by the AFM tip can 
be larger in the fully disrupted region than in the partially disrupted region – assuming that 
hydrocarbon chains are more adhesive than polar headgroups. Histograms of the reduced 
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Young’s modulus and the adhesion force maps (Fig. 6J) are consistent with our qualitative 
assessment that larger bilayer disruption results in larger bilayer rigidity and smaller bilayer 
adhesion force.
Figure 6 shows the overall contrast between the three types of regions depending on the 
degree of bilayer disruption. Scans with larger magnifications reveal more details of bilayer 
mechanical and adhesion force properties (Fig. S2, Supplementary Material). Compared to 
the fully disrupted region, the circularly or irregularly shaped patches exhibit smaller rigidity 
and larger adhesion force (Fig. S2). These properties are consistent with our earlier assertion 
that the protruded patches (by ~0.6 nm) correspond to intact bilayer regions, rather than 
polyQ35 oligomers. In addition to the intact patches, fibrils are also observed in the large-
magnification images. In particular, we find that compared to the fully disrupted region, 
fibrils have a smaller adhesion force (Fig. S2). Moreover, the rigidity of fibrils is 
comparable to that of the fully disrupted bilayer. This observation supports the notion that 
the disrupted region is enriched with polyQ35 aggregates.
DOPC bilayers exposed to polyQ35 aliquots incubated for 1 day and 9 days are shown in 
Fig. S3 (Supplementary Material). Similar to the 0-day aliquot, fibrils deposited on bilayer 
surfaces are observed in all images. Importantly, all aliquots are able to induce bilayer 
disruption. This is confirmed by comparing height variances between the intact and 
disrupted bilayers using a two-sample F-test (after excluding regions with deposited fibrils). 
The resulting p values are < 0.01 for all of the disrupted bilayers in Fig. S3. One difference 
is the intact lipid patches induced by the 0-day and 1-day aliquots, while no patches are 
observed for the 9-day aliquot. The difference could be due to different equilibration time in 
the AFM liquid cell.
One interesting question is whether lipid bilayer surface can promote or inhibit polyQ 
aggregate formation. Figure 9 shows two consecutive scans (30 min apart) for a DOPC 
bilayer exposed to 20 μM polyQ35 incubated for 0 day at 4°C. It is clear that the later scan 
contains more fibrils. Close examination indicates that some of the fibrils in the earlier scan 
(Fig. 9A) become longer in the later scan (Fig. 9B). To quantify fibril elongation, we 
calculate the aspect ratio of each fibril. This is done by digitally tracing fibril contours (Fig. 
S4, Supplementary Material). The length of each fibril is estimated based on the fibril area 
and the assumption that each fibril has the same width (e.g., 12 nm). Once the length is 
determined, the aspect ratio is the ratio of the fibril length over the constant fibril width. 
Note that a different estimation of the fibril width only shifts the aspect ratio histograms 
(Fig. 9D and 9E) to the left or right. Consistent with our preliminary assessment of fibril 
elongation, there are more fibrils with larger aspect ratios in the later scan. It seems that after 
deposition onto the bilayer surface, fibrils can continuously grow in length by recruiting 
oligomers to the vicinity of the bilayer surface.
Height profiles along two directions of a fibril in Fig. 9A indicates that the bilayer 
associated fibril has a height of ~2 nm and an apparent width of ~12 nm (Fig. 9C). Height 
probability distributions within rectangular regions containing all the fibrils support that the 
fibrils have an average height of ~2 nm larger than that of the bilayer surface (Fig. 9F and 
9G). (The rectangular regions used for histogram calculation are shown in Fig. S5, 
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Supplementary Material.) This value is smaller than the fibril height when adsorbed on mica 
surface (Figs. 1 and 2). The difference can be explained by considering that the bottom of 
the cylindrical fibrils protrudes slightly into the headgroup region of the bilayer. As a result, 
the relative height between the bilayer surface and the apex of the fibril is smaller than the 
actual height of the fibril. Fibril indentation could contribute to bilayer disruption, although 
this effect is minimal compared to the extensive disruption where fibrils are not present 
(fully disrupted region in Figs. 6 and 8).
Discussion
Globular oligomers of polyQ
Identifying different forms of polyQ aggregates is relevant to the development of therapeutic 
strategies targeting specific toxic species in expanded CAG repeat diseases [40-42]. Earlier 
kinetic studies on synthetic polyQ peptides suggested that the nucleated growth of fibrillar 
aggregates involves a critical nucleus size of one monomer [4]. Fibrils are spontaneously 
formed by the metastable monomeric nucleus. Other studies challenged this view by 
showing that soluble aggregates do form during the monomer-fibril conversion [43]. The 
apparent discrepancy was later reconciled (to some degree) by a systematic study showing 
that nucleus size is repeat length dependent [5]. Short stretches aggregate via nuclei up to 4 
monomers, while longer stretches undergo monomeric nucleation. Other studies indicated 
that flanking sequences could also modify nucleus size [6, 44, 45].
One source of confusion is the difficulty of visually detecting the various fibrillar precursors 
with polymorphic and possibly transient nature. In this regard, high-resolution AFM is 
invaluable for revealing different amyloid aggregates present on or off aggregation pathways 
of polyQ [40]. Indeed, oligomers of polyQ without or with the htt N-terminal have been 
observed using AFM [7, 46]. Although the reported dimensions vary, AFM studies support 
that multi-monomeric oligomers of long polyQ stretches do form [47]. This, however, does 
not exclude the possibility of monomeric nucleation pathway, since the preparation protocol 
[48, 49] and the mica surface [50] can alter polyQ aggregation behavior, as well as the 
peptide sequence used in each study [5, 6]. We note that our polyQ35 stock solution was 
incubated at 4°C and examined at room temperature. It has been reported that htt-polyQ 
complex contains more loop/turn structures when incubated at 4°C than at 37°C [39]. This 
observation has little effect on our data since we clearly see the intermolecular β-sheet band 
in all of the aliquots examined (Fig. 3), while this band is diminished in the reported study at 
4°C. One possibility is that all our measurements are performed at room temperature, which 
could bring the aliquots to “normal temperature” behavior.
Lipid bilayer perturbation
Cell membranes have been proposed as the primary target by an array of amyloidogenic 
proteins and peptides [13, 19, 27]. To explore membrane perturbation induced by polyQ35 
aggregates, we use a number of experimental approaches. We find that polyQ35 aggregates 
can perturb lipid bilayer integrity, yielding deflated GUVs. Our fluorescence spectroscopy 
data indicate that after exposing to polyQ35 aggregates, lipid bilayers become permeable to 
calcein. Moreover, the efficacy of calcein leakage is inversely related to the incubation time 
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of polyQ35 at 4°C. The disruptive effect of polyQ35 aggregates on lipid bilayers is further 
revealed by high-resolution solution AFM measurements. Interestingly, we find that lipid 
bilayer disruption is a two-step process. Lipid motifs such as phosphate group residing 
closer to the water-bilayer interface are first exposed, resulting in partially disrupted 
morphology; full disruption is achieved by exposing deeper lipid motifs such as the 
glycerol-carbonyl group. The observed two-step process highlights that peptide 
concentration and equilibration time can be important parameters in explaining discrepant 
membrane toxicities of amyloid aggregates. Similar lipid bilayer disruption/remodeling has 
been observed for a broad spectrum of amyloid aggregates [51-53]. Studies on interactions 
between polyQ and lipid bilayers have also been performed [25]. The authors found that 
polyQ monomers do not appreciably aggregate and disrupt lipid bilayers; addition of a 
flanking sequence significantly augments bilayer disruption. Since our data clearly show 
that simple polyQ stretches is fully capable of disrupting lipid bilayers, the discrepancy can 
be attributed to the incubation time that is required to generate toxic polyQ aggregates. We 
overcome the problem by skipping monomeric disaggregation process.
In addition to topographical information, our AFM measurements also reveal bilayer 
mechanical and adhesion force properties. We find that bilayer rigidity increases 
continuously when the bilayer undergoes partial and full disruption by polyQ35 aggregates. 
Interestingly, the adhesion force between the bilayer and the AFM tip first decreases and 
then increases during the two-step disruption process. Since proper membrane function 
requires balanced structural and mechanical properties, our AFM data provide additional 
perspective on how polyQ aggregates might hamper cellular activity. Our observation of the 
enhanced bilayer rigidity by polyQ adsorption and insertion is consistent with previous 
AFM force measurements, which showed that larger puncture forces are required for 
bilayers exposed to amyloid-β prefibrillar oligomers [21, 54]. Using an AFM mode referred 
to as the scanning probe acceleration microscopy (SPAM), Legleiter and coworkers 
measured the maximum tapping force (Fmax) and minimal tapping force (Fmin) of lipid 
bilayers during each tapping event [24, 25, 49, 55]. The authors found that addition of 
amyloid aggregates decreases Fmax and Fmin. By correlating Fmax to bilayer rigidity and 
Fmin to bilayer-tip adhesion force, the authors concluded that amyloid aggregates 
simultaneously decrease bilayer rigidity and adhesion force. While the later conclusion is in 
accordance with ours – although we obtain a two-step process, which was not seen in their 
studies – their result of smaller bilayer rigidity contradicts our data. One explanation is that 
unlike the reduced Young’s modulus, which is obtained by fitting force-distance curves, 
Fmax from SPAM only measures one force during a tapping cycle. An alternative 
explanation is that the studies by Legleiter and coworkers used a different lipid bilayer, as 
well as the addition of a flanking sequence to polyQ stretches.
It is clear that polyQ aggregates can modulate structural and mechanical properties of lipid 
bilayers. The vexing question is what aggregate is responsible for the observed change. Our 
solution AFM measurements on mica indicate that globular oligomers and short fibrils are 
the dominant aggregated forms of polyQ35. Exposing lipid bilayers to polyQ35 causes 
bilayer disruption in an equilibration time dependent manner. The final bilayer is composed 
of intact lipid patches, fully disrupted region, and polyQ fibrils (Fig. 8). Where do the 
oligomers go? The answer is hinted by the fully disrupted region without fibrils. Since 
Ho et al. Page 12
Biochim Biophys Acta. Author manuscript; available in PMC 2017 April 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
monomers do not cause bilayer disruption [13, 19], the only candidate for the observed 
change in the fully disrupted region is oligomers, i.e., polyQ35 oligomers are the toxic 
aggregates causing bilayer disruption. This conclusion is supported by several lines of 
evidence: (i) oligomers can increase the rigidity of the fully disrupted region (Fig. 6), and 
(ii) bilayer thickness (~3-4 nm) is compatible with oligomers but not fibrils (Fig. 1). 
Although controversies remain pertaining to cytotoxicity of different forms of amyloid 
aggregates [56], the implication from our data that globular oligomers cause membrane 
disruption agrees with many studies showing that formation of inert fibrils is a coping 
response to toxic oligomers [57].
Several compelling mechanisms have been suggested to explain membrane permeabilization 
induced by amyloidogenic proteins and peptides: (i) nonspecific membrane disruption [19, 
58], (ii) transmembrane pore formation [26], and (iii) detergent-like micellization [59]. 
Although the exact mechanism is most likely protein and aggregate dependent, our 
experimental data support nonspecific membrane disruption by polyQ aggregates. The 
absence of detergent-like effect is evident based on the calcein leakage data, which indicates 
that even when the leakage reaches maximum, there are still significant amount of calcein 
molecules enclosed by lipid vesicles. This will not be the case if lipids are extracted to form 
micelle-like structures with polyQ aggregates. The absence of annular pores is confirmed by 
our high-resolution solution AFM measurements (Fig. S3, Supplementary Material). Aside 
from occasional defects, the majority of the fully disrupted bilayer is homogeneous. We note 
that our solution AFM has enough resolution to see transmembrane protein oligomers of ~5 
nm diameter in lipid bilayers (unpublished data). The mechanism of generic membrane 
disruption by polyQ aggregates is consistent with several lines of experimental data [19, 58, 
60, 61].
Conclusions
In this study, we prepared aggregates of a polyQ stretch containing 35 glutamine residues at 
4°C. Depending on the incubation time, globular oligomers and short fibrils are observed 
using solution AFM on a mica surface. Size and volume estimation reveals that polyQ35 
oligomers contain ~10-13 monomers, although the estimation is complicated by 
uncertainties due to oligomer size heterogeneity and the finite size of AFM tips. PolyQ35 
fibrils have a twisted morphology and are most likely formed by intertwining two oligomer 
strings. Using attenuated total refection FTIR, we show that polyQ35 aggregates are 
enriched in intermolecular β-sheet structure; the content of β-sheet increases with incubation 
time. We also study the impact of polyQ35 aggregates on vesicular and mica supported 
planar lipid membranes. Vesicle breakage is observed using fluorescence microscopy of ~30 
μm sized GUVs. Similarly, time-dependent fluorescence spectroscopy measurement reveals 
that lipid vesicles become permeable to calcein after introducing polyQ35 aggregates. 
Interestingly, we observe that even at the maximum leakage, significant amount of calcein 
molecules are still encapsulated by lipid vesicles. This suggests that polyQ35 aggregates 
only modulate lipid membrane integrity, but do not cause membrane fragmentation. Detailed 
structural and mechanical perturbation of lipid membranes is obtained by solution AFM. We 
find that membrane disruption proceeds by partially decreasing bilayer height by ~0.2 nm, 
followed by a more aggressive decrease of ~0.4 nm (total of ~0.6 nm). In addition to the 
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height contrast, the resulting partially and fully disrupted bilayers have distinct rigidity and 
adhesion force properties compared to the intact bilayer. Specifically, the bilayer rigidity 
increases as the intact bilayer becomes partially and fully disrupted. Surprisingly, the 
adhesion force first decreases and then increases during the disruption process. Finally, we 
show that membrane associated fibrils can grow in length, although the role of lipid bilayer 
surface on polyQ aggregation (e.g., promotion or suppression of fibril growth compared to 
the aqueous solution) is unclear based on our study [56, 62].
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• PolyQ forms oligomers and fibrils
• PolyQ aggregates permeabilize lipid bilayers
• PolyQ aggregates disrupts lipid bilayer organization by a two-step process
• PolyQ aggregates modulate lipid bilayer mechanical and adhesion force 
properties
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Figure 1. 
PolyQ35 aggregates on mica surface obtained by solution AFM. (A) Height image. Scale 
bar = 50 nm. (B) Height profiles along the six trajectories indicated in (A). (Only the central 
portion containing aggregates is shown.) Globular oligomers have a height of ~2 nm and a 
width of ~10 nm; fibrils have a height of ~4 nm and a width of ~12 nm. Twisted 
morphology is seen for the fibril with a periodicity of ~13 nm along the fibril axis.
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Figure 2. 
Solution AFM height images of polyQ35 aggregates incubated for 0 day (A), 1 day (B), 2 
days (C), and 9 days (D) at 4°C. Insets show representative fibrils and oligomers with 3-time 
magnification. Images are obtained after similar equilibration times in the AFM liquid cell at 
23°C. Scale bars = 100 nm. (E–H) Height probabilities for the corresponding height images 
in (A–D).
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Figure 3. 
Attenuated total reflection FTIR absorption spectra of polyQ35 incubated for different days 
at 4°C (indicated by the values next to each spectrum). The spectrum of the pelleted 
aggregates is obtained by centrifuging an aliquot incubated for 7 days.
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Figure 4. 
Fluorescence microscopy of DOPC GUVs before and after mixing with polyQ35 aliquot. 
The peptide has been incubated for 5 days at 4°C, and the final peptide concentration is 15 
μM. Scale bars = 10 μm. The left panel shows an intact GUV. After mixing with polyQ35, 
GUVs become deflated (five representative vesicles on the right).
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Figure 5. 
Calcein leakage of DOPC ULVs induced by polyQ35 incubated for different days at 4°C, as 
well as the pelleted aggregates from a 7-day aliquot. The excitation and emission 
wavelengths are 494 and 515 nm, respectively. Calcein-encapsulated ULVs are prepared 
using SEC separation. Snap-frozen peptide aliquots are mixed with the same portion of 
ULVs to eliminate lipid concentration variation. The final peptide concentration is 10 μM. 
Time-course measurements are performed at 23°C. Fluorescence curve for ULV solution 
without polyQ35 is also shown.
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Figure 6. 
Solution AFM images of mica supported DOPC bilayers exposed to 20 μM polyQ35 
aggregates incubated for 0 day at 4°C. (A–C) Height images, (D–F) reduced Young’s 
modulus E* maps, and (G–I) adhesion force maps. Scale bars = 200 nm. The three rows 
correspond to three time points (~20 min apart) when the measurements are performed. 
Three regions are indicated as a, b, and c in (A), (D), and (G) to highlight the intact bilayer, 
the partially disrupted bilayer, and the fully disrupted bilayer, respectively. (J) Histograms 
(normalized) of the corresponding height, reduced Young’s modulus, and adhesion force 
maps at the three time points shown in (A–I).
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Figure 7. 
Solution AFM height images of a DOPC bilayer modulated by polyQ35 aggregates. (A) 
DOPC bilayer, and (B) DOPC bilayer e posed to 20μM polyQ35 aggregates incubated for 0 
day at 4°C. Scale bars = 200 nm. (C) and (D) are height profiles (in nm) along the solid 
green lines in (A) and (B), respectively. Three regions in (D) are indicated. Region a 
corresponds to intact bilayer; region b corresponds to partially disrupted bilayer; region c 
corresponds to fully disrupted bilayer. Compared to the intact bilayer, the height of the 
partially and fully disrupted bilayers is smaller by ~0.2 and ~0.6 nm, respectively.
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Figure 8. 
Solution AFM height images of DOPC bilayers exposed to 20 μM polyQ35 incubated for 0 
day (A) and 1 day (B). Intact lipid patches (C and D) and polyQ35 fibrils (E and F) are 
digitally extracted by setting appropriate height thresholds. (G) and (H) are normalized 
height probabilities for the three species: a, fibrils; b, intact lipid patches; and c, disrupted 
lipid regions. The average height difference between the disrupted and the intact lipid 
regions is ~0.6 nm. Scale bars = 100 nm.
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Figure 9. 
PolyQ35 fibril elongation on DOPC bilayer surface. Scale bars = 200 nm. Five ellipses (a–e) 
are shown to highlight where fibril elongation occurs. (C) Height profiles along two 
trajectories depicted in (A). (D) and (E) are aspect ratio histograms of polyQ35 fibrils in (A) 
and (B), respectively. (F) and (G) are height probabilities in rectangular regions containing 
all fibrils (Fig. S4, Supplementary Material). The average height difference between fibrils 
and the bilayer surface is ~2 nm.
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